Submission Details
| 510(k) Number | K863741 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 23, 1986 |
| Decision Date | November 13, 1986 |
| Days to Decision | 51 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | — |
K863741 is an FDA 510(k) clearance for the IMMUNO-CEPT D (BETA-MONOCLONAL), a Agglutination Method, Human Chorionic Gonadotropin (Class II — Special Controls, product code JHJ), submitted by Immunostics Co., Inc. (Ocean, US). The FDA issued a Cleared decision on November 13, 1986, 51 days after receiving the submission on September 23, 1986. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1155.
| 510(k) Number | K863741 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 23, 1986 |
| Decision Date | November 13, 1986 |
| Days to Decision | 51 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | — |
| Product Code | JHJ — Agglutination Method, Human Chorionic Gonadotropin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1155 |